Riskpilot← Back to searchSign inGet full accessSkepplanda Läkarhus AB
ABActiveOrg 5592265564Albotorget 5General medical practice activities · NACE 8621Est. 201916 employees
Revenue 2025
SEK 22,9M
+21% vs 2024
EBITDA margin
10.0%
-1% vs 2024
Equity ratio
54.6%
Financial strength
Net profit 2025
SEK 753K
-8% vs 2024
| Revenue | SEK 22,9M | +21% |
| EBITDA | SEK 2,3M | -1% |
| Net profit | SEK 753K | -8% |
| Total assets | SEK 5,4M | -6% |
| Equity | SEK 3M | -30% |
| Employees | 16 | — |
Legal name
Skepplanda Läkarhus AB
Org number
5592265564
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 november 2019
Share capital
SEK 50 000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva vårdcentral samt därmed förenlig verksamhet.
Address
Albotorget 5
Email
karin.svensson@lakarhusenivast.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 349 | 17 972 | 18 562 | 18 902 | 22 857 |
| Staff expenses | — | −9 879 | −12 090 | −11 706 | −12 854 |
| EBITDA | 3 604 | 4 835 | 2 497 | 2 318 | 2 293 |
| Depreciation & amort. | −186 | −186 | −212 | −270 | −245 |
| EBIT | 3 418 | 4 649 | 2 285 | 2 048 | 2 048 |
| Net financials | −88 | −20 | 24 | 5 | −1 |
| Profit before tax | 6 330 | 150 | 1 494 | 1 053 | 972 |
| Tax | −532 | −33 | −321 | −232 | −220 |
| Net profit | 5 798 | 117 | 1 174 | 821 | 753 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 089 | 7 193 | 7 853 | 5 753 | 5 401 |
| Equity | 6 587 | 2 204 | 3 378 | 4 198 | 2 951 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 2 501 | 4 900 | 4 386 | 1 466 | 2 037 |
| Total debt | 2 501 | 4 900 | 4 386 | 1 466 | 2 037 |
EBITDA margin
10.0%
This company
15.8%
Market median
-37% vs market
20212025
Equity ratio
54.6%
This company
38.2%
Market median
+43% vs market
20212025
Return on equity
25.5%
This company
18.4%
Market median
+39% vs market
20212025
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20212025
Asset turnover
4.23×
This company
1.12×
Market median
+278% vs market
20212025
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RM Chief Executive Officer | Chief Executive Officer | 2025 |
EG Chief Auditor | Chief Auditor | 2025 |
| Former (2) | ||
AM Chief Auditor | Chief Auditor | 2025 – 2025 |
BH Audit | Audit | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPEKAEL AB
Skepplanda Läkarhus AB Board members of Skepplanda Läkarhus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Mikaela Hedin Göran | Chief Auditor | 0 companies |
| Rolf Mikael Spetz | Chief Executive Officer | 0 companies |
| Bo Helge Eugén Östh | Audit | 0 companies |
| Erik Gunnar Hansson | Chief Auditor | 0 companies |
| Karin Therese Svensson Stolt | Deputy Board Member | 0 companies |